Skip to main content
SVBI logo

SVBI — Investor Relations & Filings

Ticker · 1786 ISIN · TW0001786002 TW Manufacturing
Filings indexed 1,687 across all filing types
Latest filing 2021-08-06 Regulatory Filings
Country TW Taiwan
Listing TW 1786

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
公告本公司授權科醫國際貿易(上海)有限公司擔任本公司 透明質酸法思麗(Facille)皮下填補劑產品中國大陸獨家總經銷。
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the authorization of a distributor for a product in the Chinese market. It details a business arrangement and marketing authorization but does not contain financial statements, audit information, or regulatory certifications. The document is short (947 characters) and is a factual announcement about a business relationship rather than a financial report or regulatory filing. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is also not a regulatory certification or voting result. The best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous company announcements that do not fit other specific categories.
2021-08-06 Chinese
110年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 科妍, providing information about fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It is a short, factual update without detailed financial statements or analysis. The content is typical of a regulatory announcement or compliance disclosure rather than a full report or presentation. Given the short length (601 characters) and the nature of the data, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-08-06 Chinese
110年7月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 科妍, presented in a tabular format with comparisons to the previous year. It includes notes on accounting standards (IFRS) and reporting practices. The document length is short (765 characters) and it does not contain detailed financial statements or comprehensive analysis. It appears to be a brief financial data summary rather than a full financial report or announcement. There is no indication of it being an earnings release, annual report, or regulatory filing. Given the nature and brevity, it best fits the category of Fund Information / Factsheet (FS), which is a brief summary of key company financials and market info.
2021-08-06 Chinese
公告本公司董事會通過110年第2季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1786 科妍) reporting the board's approval of the consolidated financial report for the second quarter of the year 110 (Taiwan calendar, corresponding to 2021). It includes summarized financial data such as revenue, gross profit, operating profit, net profit, EPS, total assets, liabilities, and equity for the period 110/01/01 to 110/06/30. The document is short (891 characters) and primarily serves as an announcement of the board's approval of the quarterly financial report rather than the full detailed report itself. It does not contain detailed financial statements or substantive analysis but rather key financial highlights. Therefore, it fits best as an Interim / Quarterly Report (IR) since it reports comprehensive financial data for a period shorter than a full fiscal year (half-year). H1 2021
2021-08-04 Chinese
公告本公司董事會決議變更110年股東常會召開日期及地點
AGM Information Classification · 95% confidence The document is a short announcement (793 characters) regarding a change in the date and location of the company's Annual General Meeting (AGM) for the year 110 (Taiwanese calendar year). It includes details about the board resolution, the new AGM date, time, and venue, and references regulatory compliance with the Financial Supervisory Commission's announcement on AGM postponement due to the pandemic. There is no detailed financial data, no full report, and it is clearly an announcement about the AGM logistics rather than the AGM materials themselves. According to the rules, such announcements about AGM scheduling fall under AGM Information (AGM-R).
2021-08-04 Chinese
110年第2季海外子公司投資
Interim / Quarterly Report Classification · 90% confidence The document contains financial data related to investment in overseas subsidiaries, including shareholding percentages, original investment amounts, investment balances, and recognized investment gains or losses for a specific period (110年2季, which corresponds to the second quarter of the 110th year in the Taiwanese calendar). The content is tabular and provides substantive financial data for a quarterly period. The document length is short (664 characters), but it contains actual financial figures and analysis rather than just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR), which includes comprehensive financial data for a period shorter than a full fiscal year. H1 2021
2021-08-04 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.